August 03, 2012
The Judicial Panel for Multidistrict Litigation on Thursday declined to centralize in Illinois seven class actions accusing GlaxoSmithKline LLC, Pfizer Inc. and seven other major drugmakers of racketeering and antitrust violations for allegedly subsidizing illegal co-payments for brand-name prescription drugs.
March 07, 2012
Pfizer Inc., GlaxoSmithKline PLC and six other major drugmakers were sued in class actions under federal racketeering and antitrust laws Wednesday for allegedly subsidizing illegal copayments for brand-name prescription drugs such as Lipitor and Nexium through the promotion of copay coupons.